Raymond Dwek United Therapeutics Corp (UTHR) insider trading activity

Raymond Dwek is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 1,750 shares of UTHR, which is worth approximately $654,447. The most recent transaction as insider was on Apr 28, 2022, when has been sold 2,000 shares (Common Stock) at a price of $179.34 per share, resulting in proceeds of $358,680. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.75K

0% 3M change

0% 12M change

Total Value Held $654,447

RAYMOND DWEK Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 28 2022	SELL Sale (or disposition) back to the issuer	$358,680 $179.34 p/Share	2,000 Reduced 100.0%	0 Common Stock
Apr 28 2022	BUY Exercise of conversion of derivative security	$96,220 $48.11 p/Share	2,000 Added 50.0%	2,000 Common Stock
Apr 21 2022	SELL Sale (or disposition) back to the issuer	$380,440 $190.22 p/Share	2,000 Reduced 100.0%	0 Common Stock
Apr 21 2022	BUY Exercise of conversion of derivative security	$96,220 $48.11 p/Share	2,000 Added 50.0%	2,000 Common Stock
Apr 14 2022	SELL Sale (or disposition) back to the issuer	$383,820 $191.91 p/Share	2,000 Reduced 100.0%	0 Common Stock
Apr 14 2022	BUY Exercise of conversion of derivative security	$96,220 $48.11 p/Share	2,000 Added 50.0%	2,000 Common Stock
Apr 07 2022	SELL Sale (or disposition) back to the issuer	$380,220 $190.11 p/Share	2,000 Reduced 100.0%	0 Common Stock
Apr 07 2022	BUY Exercise of conversion of derivative security	$96,220 $48.11 p/Share	2,000 Added 50.0%	2,000 Common Stock
Nov 08 2021	SELL Sale (or disposition) back to the issuer	$606,270 $202.09 p/Share	3,000 Reduced 100.0%	0 Common Stock
Nov 08 2021	BUY Exercise of conversion of derivative security	$144,330 $48.11 p/Share	3,000 Added 50.0%	3,000 Common Stock
Jun 29 2021	SELL Open market or private sale	$591,394 $176.01 p/Share	3,360 Reduced 100.0%	0 Common Stock
Jun 26 2021	BUY Exercise of conversion of derivative security	-	3,360 Added 50.0%	3,360 Common Stock
May 05 2021	SELL Sale (or disposition) back to the issuer	$396,280 $198.14 p/Share	2,000 Reduced 100.0%	0 Common Stock
May 05 2021	BUY Exercise of conversion of derivative security	$109,540 $54.77 p/Share	2,000 Added 50.0%	2,000 Common Stock
Apr 28 2021	SELL Sale (or disposition) back to the issuer	$411,240 $205.62 p/Share	2,000 Reduced 100.0%	0 Common Stock
Apr 28 2021	BUY Exercise of conversion of derivative security	$109,540 $54.77 p/Share	2,000 Added 50.0%	2,000 Common Stock
Apr 21 2021	SELL Sale (or disposition) back to the issuer	$423,860 $211.93 p/Share	2,000 Reduced 100.0%	0 Common Stock
Apr 21 2021	BUY Exercise of conversion of derivative security	$109,540 $54.77 p/Share	2,000 Added 50.0%	2,000 Common Stock
Apr 14 2021	SELL Sale (or disposition) back to the issuer	$405,560 $202.78 p/Share	2,000 Reduced 100.0%	0 Common Stock
Apr 14 2021	BUY Exercise of conversion of derivative security	$109,540 $54.77 p/Share	2,000 Added 50.0%	2,000 Common Stock
Apr 07 2021	SELL Sale (or disposition) back to the issuer	$382,200 $191.1 p/Share	2,000 Reduced 100.0%	0 Common Stock
Apr 07 2021	BUY Exercise of conversion of derivative security	$109,540 $54.77 p/Share	2,000 Added 50.0%	2,000 Common Stock
Nov 10 2020	SELL Sale (or disposition) back to the issuer	$278,560 $139.28 p/Share	2,000 Reduced 100.0%	0 Common Stock
Nov 10 2020	BUY Exercise of conversion of derivative security	$96,220 $48.11 p/Share	2,000 Added 50.0%	2,000 Common Stock
Nov 02 2020	SELL Sale (or disposition) back to the issuer	$669,900 $133.98 p/Share	5,000 Reduced 100.0%	0 Common Stock

Raymond Dwek

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account